Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Taken from Order 61
1
Jun 07, 2013 08:08PM

I believe the last paragraph will explain our reliance almost exclusively on TPL's investments with regards to the MMP. They have just concluded a successful case with the ITC regarding their other patents, so I'm hoping our reliance on them will do the same. In my mind we should have a good chance of success of meeting domestic industry requirements because of this approach. IMO of course.

Share
New Message
Please login to post a reply